Variant report

Variant	nsv970205
Chromosome Location	chr6:26703817-26705796
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 75 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:75 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs549063699	chr6:26703819-26703820	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs559043208	chr6:26703838-26703839	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs528104618	chr6:26703842-26703843	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs551758857	chr6:26703882-26703883	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs571586466	chr6:26703888-26703889	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs537381009	chr6:26703889-26703890	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs373235181	chr6:26703895-26703896	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs550759570	chr6:26703907-26703908	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs567524541	chr6:26703944-26703945	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs536308855	chr6:26703945-26703946	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs369376116	chr6:26704035-26704036	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs553447803	chr6:26704056-26704057	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs573130723	chr6:26704108-26704109	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs539003873	chr6:26704137-26704138	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs559030165	chr6:26704206-26704207	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs377596202	chr6:26704207-26704208	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs577993438	chr6:26704211-26704212	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs543785110	chr6:26704231-26704232	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs563424540	chr6:26704345-26704346	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs573786583	chr6:26704348-26704349	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs542321112	chr6:26704365-26704366	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs559420347	chr6:26704373-26704374	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs528202071	chr6:26704399-26704400	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs551339936	chr6:26704423-26704424	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs556268460	chr6:26704433-26704434	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs564577869	chr6:26704439-26704440	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs373218145	chr6:26704440-26704441	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs531063915	chr6:26704496-26704497	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs550871956	chr6:26704527-26704528	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs567486062	chr6:26704548-26704549	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs530342200	chr6:26704561-26704562	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs546908577	chr6:26704587-26704588	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs566942802	chr6:26704619-26704620	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs377713997	chr6:26704643-26704644	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs538798848	chr6:26704647-26704648	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs558986642	chr6:26704655-26704656	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs569276212	chr6:26704730-26704731	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs374998086	chr6:26704740-26704741	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs565590251	chr6:26704741-26704742	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs386406578	chr6:26704750-26704751	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs386406579	chr6:26704770-26704771	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs537299147	chr6:26704772-26704773	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs577857202	chr6:26704816-26704817	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs573726315	chr6:26704842-26704843	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs542785161	chr6:26704905-26704906	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs545019110	chr6:26704972-26704973	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs572884110	chr6:26704974-26704975	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs377690698	chr6:26705089-26705090	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs544708492	chr6:26705120-26705121	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs564501499	chr6:26705219-26705220	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Williams-beuren syndrome	16971481	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	21569311	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:24 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26701800-26704800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
2	chr6:26701800-26705000	Weak transcription	HMEC	breast
3	chr6:26702000-26704200	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr6:26702000-26704400	Weak transcription	HUES48 Cell Line	embryonic stem cell
5	chr6:26702000-26705000	Weak transcription	HUES64 Cell Line	embryonic stem cell
6	chr6:26702000-26706400	Weak transcription	H9 Cell Line	embryonic stem cell
7	chr6:26702400-26704200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr6:26702400-26704200	Weak transcription	HUES6 Cell Line	embryonic stem cell
9	chr6:26704200-26704400	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr6:26704200-26704600	Bivalent Enhancer	K562	blood
11	chr6:26704200-26705600	Enhancers	H1 Cell Line	embryonic stem cell
12	chr6:26704200-26705800	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr6:26704400-26704800	Weak transcription	HUES6 Cell Line	embryonic stem cell
14	chr6:26704400-26705600	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr6:26704400-26705600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr6:26704400-26705600	Bivalent Enhancer	HepG2	liver
17	chr6:26704800-26705200	Enhancers	HUES6 Cell Line	embryonic stem cell
18	chr6:26704800-26705600	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr6:26705000-26705400	Enhancers	NHEK	skin
20	chr6:26705000-26705600	Enhancers	HUES64 Cell Line	embryonic stem cell
21	chr6:26705000-26705600	Enhancers	HMEC	breast
22	chr6:26705200-26705600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
23	chr6:26705400-26705600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr6:26705600-26706000	Flanking Bivalent TSS/Enh	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links